NDC 65862-599-06 - Rizatriptan Benzoate
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 65862-599
- Requested NDC
- 65862-599-06
- Package NDCs from labels
- 65862-599-03, 65862-599-90, 65862-599-12, 65862-599-06, 65862-599-18
- Manufacturer
- Bryant Ranch Prepack
- Effective date
- 2024-12-10
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Rizatriptan Benzoate - Bryant Ranch Prepack | Bryant Ranch Prepack | 2024-12-10 | HUMAN PRESCRIPTION DRUG LABEL |
| Rizatriptan Benzoate - Aurobindo Pharma Limited | Aurobindo Pharma Limited | 2024-02-17 | Human Prescription Drug Label |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 65862-599-03 | Rizatriptan Benzoate | 3 in 1 BLISTER PACK | TABLET | 3 | 14 | |
| 65862-599-06 | Rizatriptan Benzoate | 6 in 1 BLISTER PACK | TABLET | 6 | 14 | |
| 65862-599-12 | Rizatriptan Benzoate | 4 in 1 CARTON | TABLET | 4 | 14 | |
| 65862-599-18 | Rizatriptan Benzoate | 3 in 1 CARTON | TABLET | 3 | 14 | |
| 65862-599-90 | Rizatriptan Benzoate | 3 in 1 CARTON | TABLET | 3 | 14 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 65862-599-03 | EA - Each | 65862-599 | a46c2ff5-ea1c-48bc-9654-a939e0e88ea2 | 1 | 2013-02-13 |
| 65862-599-12 | EA - Each | 65862-599 | 2f24a7a6-89e0-484d-96c0-86e89e81df40 | 1 | 2013-02-13 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| RIZATRIPTAN BENZOATE | ACTIVE INGREDIENT | WR978S7QHH | RIZATRIPTAN BENZOATE TABLET [AUROBINDO PHARMA LIMITED] | 3 | |
| RIZATRIPTAN | ACTIVE MOIETY | 51086HBW8G | RIZATRIPTAN BENZOATE TABLET [AUROBINDO PHARMA LIMITED] | 3 | |
| CELLULOSE, MICROCRYSTALLINE | INACTIVE INGREDIENT | OP1R32D61U | RIZATRIPTAN BENZOATE TABLET [AUROBINDO PHARMA LIMITED] | 3 | |
| FERRIC OXIDE RED | INACTIVE INGREDIENT | 1K09F3G675 | RIZATRIPTAN BENZOATE TABLET [AUROBINDO PHARMA LIMITED] | 3 | |
| LACTOSE MONOHYDRATE | INACTIVE INGREDIENT | EWQ57Q8I5X | RIZATRIPTAN BENZOATE TABLET [AUROBINDO PHARMA LIMITED] | 3 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | RIZATRIPTAN BENZOATE TABLET [AUROBINDO PHARMA LIMITED] | 3 | |
| STARCH, CORN | INACTIVE INGREDIENT | O8232NY3SJ | RIZATRIPTAN BENZOATE TABLET [AUROBINDO PHARMA LIMITED] | 3 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Rizatriptan Benzoate | RIZATRIPTAN BENZOATE | Bryant Ranch Prepack | 65ae33a2-975f-4a4e-a1a5-42fe451a2434 | 2023-03-23 | Warnings, Adverse reactions | 312840 WR978S7QHH |
| rizatriptan benzoate | RIZATRIPTAN BENZOATE | Macleods Pharmaceuticals Limited | 57ed2505-28f1-4292-b3c3-a49bf0f7c683 | 2023-02-27 | Boxed warning, Warnings, Adverse reactions | WR978S7QHH |
| Rizatriptan Benzoate | RIZATRIPTAN BENZOATE | A-S Medication Solutions | 5001b8cc-8e52-4a00-a830-3b2f79766a03 | 2023-02-06 | Warnings, Adverse reactions | 314209 WR978S7QHH |
| Rizatriptan Benzoate | RIZATRIPTAN BENZOATE | Unichem Pharmaceuticals (USA), Inc. | 35f26d3c-268b-4114-9b5b-1c2e0b9ddfd5 | 2022-11-22 | Warnings, Adverse reactions | 314209 312840 WR978S7QHH |
| Rizatriptan Benzoate | RIZATRIPTAN BENZOATE | Ascend Laboratories, LLC | 07e66554-bc85-4853-9f40-1249617630a9 | 2022-09-30 | Warnings, Adverse reactions | 314209 312840 WR978S7QHH |
| Rizatriptan | RIZATRIPTAN | Macleods Pharmaceuticals Limited | 27bc2cfc-fefb-4b50-a0dc-6268c69b4902 | 2022-07-01 | Warnings, Adverse reactions | 314209 312840 WR978S7QHH |
| Rizatriptan Benzoate | RIZATRIPTAN BENZOATE | Proficient Rx LP | 4a5b43f6-a5ea-4d6f-941f-3c19f242c896 | 2022-05-01 | Warnings, Adverse reactions | ANDA202490 314209 WR978S7QHH |
| Rizatriptan Benzoate | RIZATRIPTAN BENZOATE | Cipla USA Inc. | f462a507-921c-41c2-93ba-36003b6e8914 | 2022-01-13 | Warnings, Adverse reactions | 314209 312840 WR978S7QHH |
| RIZATRIPTAN BENZOATE | RIZATRIPTAN BENZOATE | Bionpharma Inc., | 91e160d6-f23f-e5e0-baec-908b2d25ce3c | 2021-03-02 | Warnings, Adverse reactions | WR978S7QHH |
| Rizatriptan Benzoate | RIZATRIPTAN BENZOATE | Unichem Pharmaceuticals (USA), Inc. | 3cdeccf6-36dd-4a9e-9687-2f7cce47af5f | 2020-04-08 | Warnings, Adverse reactions | WR978S7QHH |
| Rizatriptan Benzoate | RIZATRIPTAN BENZOATE | Proficient Rx LP | f5520526-1cc5-489f-b142-92f92fec77d3 | 2020-02-01 | Warnings, Adverse reactions | WR978S7QHH |
| Rizatriptan Benzoate | RIZATRIPTAN BENZOATE | Teva Pharmaceuticals USA, Inc. | 4ef60c83-ba48-4134-968b-13800ea9b7f2 | 2019-10-01 | Warnings, Adverse reactions | 314209 312840 WR978S7QHH |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.